Connection

Taixing Cui to Myocytes, Cardiac

Back to Details
This is a "connection" page, showing publications Taixing Cui has written about Myocytes, Cardiac.
Taixing Cui
Connection Strength
3.936
Myocytes, Cardiac
  1. CYLD exaggerates pressure overload-induced cardiomyopathy via suppressing autolysosome efflux in cardiomyocytes. J Mol Cell Cardiol. 2020 08; 145:59-73.
    View in: PubMed
    Score: 0.562
  2. Nuclear factor erythroid-2 related factor 2 (Nrf2)-mediated protein quality control in cardiomyocytes. Front Biosci (Landmark Ed). 2016 01 01; 21(1):192-202.
    View in: PubMed
    Score: 0.412
  3. A critical role of cardiac fibroblast-derived exosomes in activating renin angiotensin system in cardiomyocytes. J Mol Cell Cardiol. 2015 Dec; 89(Pt B):268-79.
    View in: PubMed
    Score: 0.407
  4. Identifying panaxynol, a natural activator of nuclear factor erythroid-2 related factor 2 (Nrf2) from American ginseng as a suppressor of inflamed macrophage-induced cardiomyocyte hypertrophy. J Ethnopharmacol. 2015 Jun 20; 168:326-36.
    View in: PubMed
    Score: 0.392
  5. Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction. Oxid Med Cell Longev. 2014; 2014:748524.
    View in: PubMed
    Score: 0.368
  6. Nrf2 enhances myocardial clearance of toxic ubiquitinated proteins. J Mol Cell Cardiol. 2014 Jul; 72:305-15.
    View in: PubMed
    Score: 0.366
  7. Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo. Diabetes. 2011 Feb; 60(2):625-33.
    View in: PubMed
    Score: 0.293
  8. An essential role of Nrf2 in American ginseng-mediated anti-oxidative actions in cardiomyocytes. J Ethnopharmacol. 2010 Jul 20; 130(2):222-30.
    View in: PubMed
    Score: 0.279
  9. Dihydro-CDDO-trifluoroethyl amide (dh404), a novel Nrf2 activator, suppresses oxidative stress in cardiomyocytes. PLoS One. 2009 Dec 21; 4(12):e8391.
    View in: PubMed
    Score: 0.272
  10. TFEB activation protects against cardiac proteotoxicity via increasing autophagic flux. J Mol Cell Cardiol. 2017 12; 113:51-62.
    View in: PubMed
    Score: 0.117
  11. Nrf2-Mediated Cardiac Maladaptive Remodeling and Dysfunction in a Setting of Autophagy Insufficiency. Hypertension. 2016 Jan; 67(1):107-17.
    View in: PubMed
    Score: 0.102
  12. Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2. J Mol Cell Cardiol. 2015 Jul; 84:143-53.
    View in: PubMed
    Score: 0.098
  13. Up-regulation of p27(kip1) contributes to Nrf2-mediated protection against angiotensin II-induced cardiac hypertrophy. Cardiovasc Res. 2011 May 01; 90(2):315-24.
    View in: PubMed
    Score: 0.073
  14. Nrf2 protects against maladaptive cardiac responses to hemodynamic stress. Arterioscler Thromb Vasc Biol. 2009 Nov; 29(11):1843-50.
    View in: PubMed
    Score: 0.066
  15. Rad GTPase deficiency leads to cardiac hypertrophy. Circulation. 2007 Dec 18; 116(25):2976-2983.
    View in: PubMed
    Score: 0.059
  16. An inhibitor role of Nrf2 in the regulation of myocardial senescence and dysfunction after myocardial infarction. Life Sci. 2020 Oct 15; 259:118199.
    View in: PubMed
    Score: 0.035
  17. The Calcineurin-TFEB-p62 Pathway Mediates the Activation of Cardiac Macroautophagy by Proteasomal Malfunction. Circ Res. 2020 07 31; 127(4):502-518.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.